Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03773549 · ClinicalTrials.gov registry record

A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
58
Enrollment target

NCT03773549: Completed study, sponsored by Massachusetts General Hospital.

NCT03773549 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03773549 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
58 participants
Enrollment target

Study Summary

Previous research shows that individuals with Body Dysmorphic Disorder (BDD) misinterpret ambiguous social information in a negative and threatening manner. These erroneous threat appraisals are thought to maintain disorder symptomatology and psychosocial impairment by reinforcing individuals' distorted self-image and ideas of social undesirability. Thus, maladaptive interpretation biases represent an important treatment target for this population; however, existing bias assessments and modification protocols are limited by the hypothetical and distal nature of scenarios and do not capture momentary experiential threat processes. The proposed study seeks to test virtual reality (VR) technology as a novel, in vivo means of eliciting, identifying, and measuring threat interpretation biases in a clinical sample to better understand the fear/threat structure activated during social interactions in BDD. Findings have the potential to enhance our understanding of disorder maintenance and identify more nuanced treatment targets. This study represents a critical first step in the long-term goal of harnessing VR gaming technology to supercharge existing treatment approaches for this debilitating illness.

Interventions

  • OTHER Virtual reality experience

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2019-03-01
Est. Completion 2019-09-20

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03773549

The ClinicalTrials.gov registry entry for NCT03773549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Virtual reality experience is the first listed.

NCT03773549 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03773549 about?

NCT03773549 is a clinical study titled "A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder". Previous research shows that individuals with Body Dysmorphic Disorder (BDD) misinterpret ambiguous social information in a negative and threatening manner. These erroneous threat appraisals are thought to maintain disorder symptomatology and psychosocial impairment by reinforcing individuals' disto...

What is the current status of trial NCT03773549?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2019-03-01. Estimated completion is 2019-09-20.

What interventions are being tested in trial NCT03773549?

The interventions under investigation include: Virtual reality experience (OTHER).

Who is sponsoring clinical trial NCT03773549?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.